Radio 2 has launched a service for mobile phone users. Listeners on the move can now access schedule information, features, competitions, and view the Radio 2 studio webcams via their internet ...

Boston-based Vertex Pharmaceuticals, maker of a suite of cystic fibrosis (CF) drugs, is aggressively expanding its drug development portfolio with the acquisition of Semma Therapeutics ...

The vertex shader is used to transform the attributes of vertices (points of a triangle) such as color, texture, position and direction from the original color space to the display space.

Read the latest news of the day, deep-dives on important topics to help you understand your world, and the quirky fun stories you'll want to share with your friends, all in one place.

M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated ...

HOUSTON, September 06, 2024--(BUSINESS WIRE)--Vertex Energy, Inc ... the future production of the Company’s Mobile Refinery; anticipated and unforeseen events which could reduce future ...

Eleanor Oldroyd: 30 years of "my radio family" Eleanor Oldroyd on 30 years of broadcasting at 5 Live. Ian Moore, Kath Merry, Manny Brown, Thom Gibbs Ian Moore, Kath Merry, Manny Brown and Thom ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than ...

Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.